Regenerative Bio Holding (HK) Limited – Trademark Portfolio

Entity Type: 99

Regenerative Bio Holding (HK) Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include LAIFE and OVAREVIVE. The owner is based in Chaoyang Dist.,Beijing.

11A2, Hanwei Plz., No. 7 Guanghua Rd.

Chaoyang Dist.,Beijing 100020 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OVAREVIVE
OVAREVIVE
Registered 2023
LAIFE
LAIFE
Registered 2021

Trademark Classifications

Regenerative Bio Holding (HK) Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Regenerative Bio Holding (HK) Limited have?

Regenerative Bio Holding (HK) Limited has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Regenerative Bio Holding (HK) Limited file in?

Regenerative Bio Holding (HK) Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Regenerative Bio Holding (HK) Limited's most well-known trademarks?

Regenerative Bio Holding (HK) Limited's registered trademark portfolio includes well-known marks such as LAIFE and OVAREVIVE. These are among 2 currently registered trademarks in the portfolio.

What is Regenerative Bio Holding (HK) Limited's trademark registration success rate?

Regenerative Bio Holding (HK) Limited has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.